| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:1641.)
© 2007 American Heart Association, Inc.
Research Reports |
From the Department of Neurology and Neurosurgery (J.L.R.-S., E.C., S.R.-V., J.J.P.-M., S.G.-C.), Hospital Civil de Guadalajara "Fray Antonio Alcalde," Guadalajara, Mexico; and the Department of Neurosciences (J.L.R.-S.), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Correspondence to José L. Ruiz-Sandoval, MD, Servicio de Neurología y Neurocirugía, Hospital Civil de Guadalajara "Fray Antonio Alcalde," Guadalajara, Jalisco, México, C.P. 44280. E-mail jorusan{at}mexis.com
Background and Purpose— This study aimed to independently derive an intracerebral hemorrhage grading scale (ICH-GS) for prediction of 3 outcome measures.
Methods— We evaluated 378 patients with primary ICH at hospital arrival and during the next 30 days. Independent predictors were identified by multivariate models of in-hospital and 30-day mortality. Points were allotted to each predictor based on its prognostic performance. ICH-GS was also evaluated to predict good 30-day functional status and ICH-GS was compared with the ICH score as the reference scoring system.
Results— Independent predictors were age, Glasgow Coma Scale, ICH location, ICH volume, and intraventricular extension, all components of the ICH score. Nevertheless, different cutoffs and scoring improved substantially the prognostic power of the predictors. Compared with the ICH score, ICH-GS explained more variance in the 3 outcome measures, had higher sensitivity in predicting in-hospital and 30-day mortality, and performed equally well in predicting good functional outcome at 30 days follow up.
Conclusions— The derived ICH-GS is a simple yet robust scale in predicting in-hospital and 30-day mortality, as well as good 30-day functional status, with equivalent performance.
Key Words: intracerebral hemorrhage mortality outcome prognosis risk factors
This article has been cited by other articles:
![]() |
C. D. Barras, B. M. Tress, S. Christensen, L. MacGregor, M. Collins, P. M. Desmond, B. E. Skolnick, S. A. Mayer, J. P. Broderick, M. N. Diringer, et al. Density and Shape as CT Predictors of Intracerebral Hemorrhage Growth Stroke, April 1, 2009; 40(4): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Mayer, S. M. Davis, B. E. Skolnick, N. C. Brun, K. Begtrup, J. P. Broderick, M. N. Diringer, and T. Steiner Can a Subset of Intracerebral Hemorrhage Patients Benefit From Hemostatic Therapy With Recombinant Activated Factor VII? Stroke, March 1, 2009; 40(3): 833 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Rost, E. E. Smith, Y. Chang, R. W. Snider, R. Chanderraj, K. Schwab, E. FitzMaurice, L. Wendell, J. N. Goldstein, S. M. Greenberg, et al. Prediction of Functional Outcome in Patients With Primary Intracerebral Hemorrhage: The FUNC Score Stroke, August 1, 2008; 39(8): 2304 - 2309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Di Napoli and D. A. Godoy Clinical Grading Scales in Spontaneous Intracerebral Hemorrhage Stroke, November 1, 2007; 38(11): e133 - e135. [Full Text] [PDF] |
||||
![]() |
J. L. Ruiz-Sandoval and E. Chiquete Response to Letter by Di Napoli and Godoy Stroke, November 1, 2007; 38(11): e136 - e136. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |